FDA Enforcement Class III Terminated

Vergene Amplification Tray - 700uL, BC-GP REF 20-011-018 The Verigene(R) Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI). BC-GP is performed directly on blood culture bottles identified as positive by a continuous monitoring blood culture system and which contain gram-positive bacteria.

Recall: Z-0822-2019 · Reported February 20, 2019

Enforcement

Recall Number
Z-0822-2019
Event ID
81890
Classification
Class III
Status
Terminated
Product Type
Devices
Firm
Luminex Corporation
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
February 20, 2019
Initiation Date
December 26, 2018
Classification Date
February 11, 2019
Termination Date
August 4, 2020
Address
12212 Technology Blvd, N/A, Austin, TX, 78727-6101, United States

Description

Vergene Amplification Tray - 700uL, BC-GP REF 20-011-018 The Verigene(R) Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI). BC-GP is performed directly on blood culture bottles identified as positive by a continuous monitoring blood culture system and which contain gram-positive bacteria.

Reason

On lot of VERIGENE(R) BC-GP Utility Kits (20-011-018) were labeled with the VERIGENE(R) Amplification Tray label.

Code Info

UDI: 00857573006287, Lots: 110318018C, 111018018D

Distribution

Worldwide Distribution: US (nationwide) and countries of: Austria, and Italy.

Quantity

1132 carriers